Contact Us

Get 30% Free Customization on This Report

Published Date: September, 2019

Bisphosphonates Market (Therapeutic Areas - Cancer, and Degenerative Bone Diseases; Application - Orthopedics, Oncology, and Gynecology; Distribution Channel - Hospitals, Online Channels, and Retail Pharmacies; Mode of Delivery - Oral, and Intravenous): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on bisphosphonates market provides an in-depth analysis of segments and sub-segments in the global as well as regional bisphosphonates market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional bisphosphonates market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global bisphosphonates market. According to the report, the global bisphosphonates market is projected to grow at a CAGR of 5.9% over the forecast period of 2019-2025.

 

Market Insight

The key players in the bisphosphonates market are Merck & Co., Inc., Sanofi-Aventis, F. Hoffmann-La Roche Ltd., Novartis International AG, Procter & Gamble Company, Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Apotex Inc., Cobalt Pharmaceuticals Inc., Genentech Inc., and other companies. The companies are adopting strategies such as mergers, acquisitions, and new product launches to maximize their market share.

 

The growing geriatric population drives the growth of the bisphosphonates market. The increasing number of women in the post-menopausal stage stimulates the growth of the bisphosphonates market. A post-menopausal woman loses bone density and suffers from the weakening of bone. Aged people get fractures due to a decrease in bone density and weakening of bones. The increasing prevalence of bone diseases contributes to the growth of the bisphosphonates market. There is a rise in the number of patients suffering from osteoporosis. In 2017, as per International Osteoporosis Foundation, around 200 million people worldwide suffered from osteoporosis. Bisphosphonates are beneficial to prevent bone damage and strengthen and hardens bones. Bisphosphonates are widely used to cure bone-related diseases such as osteoporosis, bone metastasis, and myeloma. Bisphosphonates are also useful to cure patients suffering from breast cancer and prostate cancer. On the other side, side effects of bisphosphonates like incapacitating bone, joint and musculoskeletal pain restrain the growth of bisphosphonates market. Moreover, research brings novel uses and benefits of bisphosphonates that creates novel opportunities for the bisphosphonates market.

 

Geographically, North America is expected to hold a dominant share in the global bisphosphonates market. The rising healthcare spending in the USA drives the growth of North America's bisphosphonates market. The increasing prevalence of myeloma in Europe contributes to the growth of the bisphosphonates market in Europe. Asia-Pacific region is anticipated to grow in the global bisphosphonates market with a healthy CAGR over the forecast period. The growing number of cases of osteoporosis and rising geriatric population stimulate the growth of the Asia-Pacific bisphosphonates market.

 

Segment Covered

The report on global bisphosphonates market covers segments such as therapeutic areas, application, distribution channel, and mode of delivery. On the basis of therapeutic areas, the sub-markets include cancer, and degenerative bone diseases. On the basis of application, the sub-markets include orthopedics, oncology, and gynecology. On the basis of the distribution channel, the sub-markets include hospitals, online channels, and retail pharmacies. On the basis of mode of delivery, the sub-markets include oral, and intravenous.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Merck & Co., Inc., Sanofi-Aventis, F. Hoffmann-La Roche Ltd., Novartis International AG, Procter & Gamble Company, Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Apotex Inc., Cobalt Pharmaceuticals Inc., Genentech Inc., and other companies.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of bisphosphonates market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

Related Reports

sign up for our newsletter